Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (2 active)

Company-led only

1 result

Therapy	Approach	Progress	Population	Additional Info
EHT102 by EuHearingShanghai EuHearing Therapeutics Co., Ltd Compare	Gene Therapy	Stage: Phase 1/2Status: Active	Children · 1–17 yearsBiallelic OTOF DFNB9 severe-to-profound deafness

Shanghai EuHearing Therapeutics Co., Ltd · Gene Therapy · Phase 1/2

ActiveTherapeutic

Population

Children · 1–17 years

Biallelic OTOF DFNB9 severe-to-profound deafness

Evidence

trial

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.